Back to top

medical: Archive

Zacks Equity Research

Stryker Shares May Gain on the Completion of the Acquisition of NICO

SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.

DGXNegative Net Change UHSPositive Net Change SYKNegative Net Change ABMNegative Net Change

Zacks Equity Research

EMA Committee Endorses AbbVie's Elahere in Ovarian Cancer

If approved, this will be the first regulatory approval for ABBV's Elahere in the European Union.

AZNNegative Net Change PFEPositive Net Change MRKNegative Net Change ABBVPositive Net Change

Zacks Equity Research

Sanofi's Sarclisa Gets FDA Nod for Expanded Use in Multiple Myeloma

This latest FDA decision marks the first approval for SNY's Sarclisa as a first-line treatment for multiple myeloma patients.

REGNNegative Net Change SNYPositive Net Change BMYPositive Net Change JNJNegative Net Change

Zacks Equity Research

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe

AngioDynamics' RECOVER-AV trial evaluates the AlphaVac F1885 System's safety and efficacy in treating acute pulmonary embolism in Europe.

ANGONegative Net Change UHSPositive Net Change AVAHPositive Net Change ATIPNegative Net Change

Zacks Equity Research

TNDM Stock Likely to Gain From Innovation Amid Competition

Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for people living with the condition.

AXGNPositive Net Change TNDMNegative Net Change KIDSNegative Net Change TMDXNegative Net Change

Zacks Equity Research

EDAP's Avenda Deal for AI-Assisted Cancer Care Likely to Drive Stock

When combined with EDAP's Focal One platform, Avenda's Unfold AI enables more accurate and patient-specific treatment options.

EDAPPositive Net Change AXGNPositive Net Change KIDSNegative Net Change TMDXNegative Net Change

Zacks Equity Research

TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU

Tandem Diabetes' t:slim X2 insulin pump is now compatible with Lilly's Lyumjev in the European Union.

BSXNegative Net Change LLYPositive Net Change PAHCPositive Net Change TNDMNegative Net Change

Santanu Roy

Take the Zacks Approach to Beat the Markets: Phibro Animal Health, Travelzoo, Ollie's Bargain Outlet in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

AMTNegative Net Change PSANegative Net Change PHMNegative Net Change ORCLNegative Net Change PAHCPositive Net Change FINegative Net Change OLLINegative Net Change AXONNegative Net Change NOBLPositive Net Change SBFGNegative Net Change TZOONegative Net Change SOLVNegative Net Change

Zacks Equity Research

New Strong Buy Stocks for September 23rd

OPRA, SBSI, AU, AHR and LYTS have been added to the Zacks Rank #1 (Strong Buy) List on September 23, 2024.

AUNegative Net Change SBSINegative Net Change LYTSNegative Net Change OPRAPositive Net Change AHRPositive Net Change

Zacks Equity Research

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

UHSPositive Net Change CORNegative Net Change AVAHPositive Net Change ATIPNegative Net Change

Zacks Equity Research

Longboard Stock Soars on FDA Designations for Epilepsy Drug

The FDA grants orphan drug and rare pediatric disease designations to LBPH's lead pipeline drug for the treatment of Dravet Syndrome.

ILMNNegative Net Change KRYSNegative Net Change BVSPositive Net Change LBPHNegative Net Change

Zacks Equity Research

J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC

With this approval, JNJ's Rybrevant is now approved for a total of four indications in the United States.

AZNNegative Net Change JNJNegative Net Change ILMNNegative Net Change KRYSNegative Net Change

Zacks Equity Research

SNN Stock Rises on the Completion of First Case With CATALYSTEM System

Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.

DGXNegative Net Change UHSPositive Net Change SNNPositive Net Change ABMNegative Net Change

Kaibalya Pravo Dey

UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?

With expansion into targeted markets and strategic diversification, UNH still has significant growth potential left.

UNHPositive Net Change HUMPositive Net Change CINegative Net Change

Ahan Chakraborty

NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?

Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the stellar performance of its GLP-1 drugs.

NVOPositive Net Change LLYPositive Net Change AMGNNegative Net Change VKTXNegative Net Change

Zacks Equity Research

GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch

GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.

UHSPositive Net Change AVAHPositive Net Change ATIPNegative Net Change GEHCPositive Net Change

Zacks Equity Research

How HCA Healthcare (HCA) Stock Stands Out in a Strong Industry

HCA Healthcare (HCA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

HCANegative Net Change

Zacks Equity Research

Roche Antiviral Drug Reduces Transmission in Late-stage Study

Results from a late-stage study on RHHBY's Xofluza show that the drug reduces the transmission of influenza from an infected person to household members.

RHHBYPositive Net Change PFEPositive Net Change LLYPositive Net Change BAYRYPositive Net Change

Zacks Equity Research

Do Options Traders Know Something About Enhabit (EHAB) Stock We Don't?

Investors need to pay close attention to Enhabit (EHAB) stock based on the movements in the options market lately.

EHABNegative Net Change

Zacks Equity Research

New Strong Sell Stocks for September 20th

AMKR, BW and AMFPF have been added to the Zacks Rank #5 (Strong Sell) List on September 20 2024.

AMKRNegative Net Change BWPositive Net Change AMFPFNegative Net Change

Zacks Equity Research

Implied Volatility Surging for Tactile Systems (TCMD) Stock Options

Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.

TCMDNegative Net Change

Zacks Equity Research

BiomX Stock Gains From Favorable Study Data Presentation on BX004

PHGE is set to present data from its Phase 1b/2a study for BX004 at the North American Cystic Fibrosis Conference in Boston on Sept. 27 and Sept. 28.

AXGNPositive Net Change KIDSNegative Net Change TMDXNegative Net Change PHGEPositive Net Change

Indrajit Bandyopadhyay

4 Stocks to Buy Amid Dental Supplies Industry Challenges

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.

BDXPositive Net Change MCKNegative Net Change COONegative Net Change STAAPositive Net Change

Zacks Equity Research

Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles

Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.

BSXNegative Net Change ALCPositive Net Change AXGNPositive Net Change PAHCPositive Net Change

Zacks Equity Research

DGX Stock to Benefit From New Partnership With Sentara Health Plans

Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.

BSXNegative Net Change DGXNegative Net Change AXGNPositive Net Change PAHCPositive Net Change